P615 Efficacy of vedolizumab in patients with Crohn's disease may differ depending on the disease location: The UCLH experience (2018)

First Author: Kumagai T

Attributed to: Pathogenesis of Ulcerative colitis: The role of BRINP3 in colonic epithelial barrier function and mucosal inflammation funded by MRC

No abstract provided

Type: Journal Article/Review

Parent Publication: Journal of Crohn's and Colitis

Issue: supplement_1